WhyPeptides

ClinicalTrials.gov research-record information

ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Austin, TX

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 23 results; after an exact city/state check of listed facilities, 21 records were retained for Austin, Texas. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Austin, Texas
Exact-location inclusion rule
A listed facility city and state must match Austin, Texas.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
7 records
NOT_YET_RECRUITING
3 records
ACTIVE_NOT_RECRUITING
11 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 21 exact-location records and 15 listed facilities. All 21 retained records are shown below.

NCT07564414

Registry title: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diab & Endo, P.A.Austin, Texas 78731
  • Velocity Clinical Research AustinAustin, Texas 78759

NCT06143956

Registry title: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical Research AustinAustin, Texas 78745

NCT07112872

Registry title: A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & Endocrinology, P.A.Austin, Texas 78731

NCT07165028

Registry title: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical Research AustinAustin, Texas 78745
  • American Research CorporationAustin, Texas 78757
  • Pinnacle Clinical ResearchAustin, Texas 78757

NCT07607587

Registry title: Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Elligo Clin Res CentreAustin, Texas 78704

NCT07668388

Registry title: A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical ResearchAustin, Texas 78745

NCT07668414

Registry title: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & EndocrinologyAustin, Texas 78749

NCT06383390

Registry title: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical Research AustinAustin, Texas 78745

NCT05726227

Registry title: A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & EndocrinologyAustin, Texas 78731

NCT07502508

Registry title: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • Elligo Health Research, Inc.Austin, Texas 78704

NCT06534411

Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Velocity Clin Res AustinAustin, Texas 78759

NCT05882045

Registry title: A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & Endocrinology, P.A.Austin, Texas 78731
  • Pinnacle Clinical ResearchAustin, Texas 78757

NCT07035093

Registry title: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • FutureSearch Trials of NeurologyAustin, Texas 78731

NCT06965413

Registry title: A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & Endocrinology, P.A.Austin, Texas 78731

NCT06914895

Registry title: A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & Endocrinology, P.A.Austin, Texas 78731

NCT03811561

Registry title: A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Central Texas Clinical ResearchAustin, Texas 78705
  • Texas Diab & Endo, P.A.Austin, Texas 78731

NCT05929079

Registry title: A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • FutureSearch Trials of NeurologyAustin, Texas 78731

NCT06173778

Registry title: Semaglutide for Post-Smoking Cessation Weight Management

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • The University of Texas at AustinAustin, Texas 78723

NCT05556512

Registry title: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Texas Diabetes & Endocrinology, P.A.Austin, Texas 78749
  • Pinnacle Clinical ResearchAustin, Texas 78757

NCT06603571

Registry title: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • IMA Clinical Research AustinAustin, Texas 78745

NCT06737042

Registry title: Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Elligo Clinical Research Center - AustinAustin, Texas 78704

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 23 results. After an exact city/state check of listed facilities, 21 records were retained for Austin, Texas, across 15 listed facilities. All 21 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
23
Exact-location records retained
21
Listed facilities retained
15
Records shown
21 of 21
Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.